Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124532792 | 12453279 | 2 | F | 201606 | 20160707 | 20160609 | 20160712 | PER | US-CELGENEUS-USA-2016061958 | CELGENE | 70.14 | YR | F | Y | 61.74000 | KG | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124532792 | 12453279 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | A2108B | 21880 | 25 | MG | CAPSULES | ||||||
| 124532792 | 12453279 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | A2108B | 21880 | 25 | MG | CAPSULES | QD | |||||
| 124532792 | 12453279 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | 20 | MG | UNKNOWN | ||||||
| 124532792 | 12453279 | 4 | C | Propanolol | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | 10 MILLIGRAM | 0 | 10 | MG | UNKNOWN | |||||||
| 124532792 | 12453279 | 5 | C | COSOPT | DORZOLAMIDE HYDROCHLORIDETIMOLOL MALEATE | 1 | Ophthalmic | 0 | EYE DROPS | ||||||||||
| 124532792 | 12453279 | 6 | C | XALATAN | LATANOPROST | 1 | Ophthalmic | .005 PERCENT | 0 | .005 | PCT | EYE DROPS | |||||||
| 124532792 | 12453279 | 7 | C | Calcium | CALCIUM | 1 | Oral | 600 MILLIGRAM | 0 | 600 | MG | CAPSULES | |||||||
| 124532792 | 12453279 | 8 | C | Baby Aspirin | ASPIRIN | 1 | Unknown | 81 MILLIGRAM | 0 | 81 | MG | UNKNOWN | |||||||
| 124532792 | 12453279 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 100 | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124532792 | 12453279 | 1 | Plasma cell myeloma |
| 124532792 | 12453279 | 3 | Product used for unknown indication |
| 124532792 | 12453279 | 4 | Product used for unknown indication |
| 124532792 | 12453279 | 5 | Product used for unknown indication |
| 124532792 | 12453279 | 6 | Product used for unknown indication |
| 124532792 | 12453279 | 7 | Product used for unknown indication |
| 124532792 | 12453279 | 8 | Product used for unknown indication |
| 124532792 | 12453279 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124532792 | 12453279 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124532792 | 12453279 | Ageusia | |
| 124532792 | 12453279 | Asthenia | |
| 124532792 | 12453279 | Decreased appetite | |
| 124532792 | 12453279 | Dysphonia | |
| 124532792 | 12453279 | Fatigue | |
| 124532792 | 12453279 | Immune system disorder | |
| 124532792 | 12453279 | Parainfluenzae virus infection | |
| 124532792 | 12453279 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124532792 | 12453279 | 1 | 20130923 | 0 | ||
| 124532792 | 12453279 | 2 | 201603 | 0 |